Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin

Peroxisome proliferator-activated receptor α (PPARα) plays a role in the pathogenesis of cardiac hypertrophy, although its underlying mechanism remains unclear. The purpose of this study was to evaluate the effect of PPARα activation on endothelin-1- (ET-1-) caused cardiomyocyte hypertrophy and expl...

Full description

Saved in:
Bibliographic Details
Main Authors: Hsu-Lung Jen, Po-Len Liu, Yung-Hsiang Chen, Wei-Hsian Yin, Jaw-Wen Chen, Shing-Jong Lin
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2016/5609121
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562971963817984
author Hsu-Lung Jen
Po-Len Liu
Yung-Hsiang Chen
Wei-Hsian Yin
Jaw-Wen Chen
Shing-Jong Lin
author_facet Hsu-Lung Jen
Po-Len Liu
Yung-Hsiang Chen
Wei-Hsian Yin
Jaw-Wen Chen
Shing-Jong Lin
author_sort Hsu-Lung Jen
collection DOAJ
description Peroxisome proliferator-activated receptor α (PPARα) plays a role in the pathogenesis of cardiac hypertrophy, although its underlying mechanism remains unclear. The purpose of this study was to evaluate the effect of PPARα activation on endothelin-1- (ET-1-) caused cardiomyocyte hypertrophy and explore its underlying mechanisms. Human cardiomyocytes (HCMs) were cultured with or without ET-1, whereafter the inhibitory effects of fenofibrate, a PPARα activator, on cell size and adiponectin protein were tested. We examined the activation of extracellular signal-regulated kinase (ERK) and p38 proteins caused by ET-1 and the inhibition of the ERK and p38 pathways on ET-1-induced cell size and adiponectin expression. Moreover, we investigated the interaction of PPARα with adiponectin and nuclear factor-κB (NF-κB) by electrophoretic mobility shift assays and coimmunoprecipitation. ET-1 treatment significantly increased cell size, suppressed PPARα expression, and enhanced the expression of adiponectin. Pretreatment with fenofibrate inhibited the increase in cell size and enhancement of adiponectin expression. ET-1 significantly activated the ERK and p38 pathways, whereas PD98059 and SB205380, respectively, inhibited them. Our results suggest that activated PPARα can decrease activation of adiponectin and NF-κB and inhibit ET-1-induced cardiomyocyte hypertrophy.
format Article
id doaj-art-babf71f95c714a36b91f43e81edac7a3
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-babf71f95c714a36b91f43e81edac7a32025-02-03T01:21:24ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/56091215609121Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and AdiponectinHsu-Lung Jen0Po-Len Liu1Yung-Hsiang Chen2Wei-Hsian Yin3Jaw-Wen Chen4Shing-Jong Lin5Division of Cardiology, Cheng-Hsin General Hospital, Taipei, TaiwanDepartment of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, TaiwanDivision of Cardiology, Cheng-Hsin General Hospital, Taipei, TaiwanInstitute of Clinical Medicine, Faculty of Medicine, Institute of Pharmacology, and Cardiovascular Research Centre, National Yang-Ming University, Taipei, TaiwanInstitute of Clinical Medicine, Faculty of Medicine, Institute of Pharmacology, and Cardiovascular Research Centre, National Yang-Ming University, Taipei, TaiwanPeroxisome proliferator-activated receptor α (PPARα) plays a role in the pathogenesis of cardiac hypertrophy, although its underlying mechanism remains unclear. The purpose of this study was to evaluate the effect of PPARα activation on endothelin-1- (ET-1-) caused cardiomyocyte hypertrophy and explore its underlying mechanisms. Human cardiomyocytes (HCMs) were cultured with or without ET-1, whereafter the inhibitory effects of fenofibrate, a PPARα activator, on cell size and adiponectin protein were tested. We examined the activation of extracellular signal-regulated kinase (ERK) and p38 proteins caused by ET-1 and the inhibition of the ERK and p38 pathways on ET-1-induced cell size and adiponectin expression. Moreover, we investigated the interaction of PPARα with adiponectin and nuclear factor-κB (NF-κB) by electrophoretic mobility shift assays and coimmunoprecipitation. ET-1 treatment significantly increased cell size, suppressed PPARα expression, and enhanced the expression of adiponectin. Pretreatment with fenofibrate inhibited the increase in cell size and enhancement of adiponectin expression. ET-1 significantly activated the ERK and p38 pathways, whereas PD98059 and SB205380, respectively, inhibited them. Our results suggest that activated PPARα can decrease activation of adiponectin and NF-κB and inhibit ET-1-induced cardiomyocyte hypertrophy.http://dx.doi.org/10.1155/2016/5609121
spellingShingle Hsu-Lung Jen
Po-Len Liu
Yung-Hsiang Chen
Wei-Hsian Yin
Jaw-Wen Chen
Shing-Jong Lin
Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
Mediators of Inflammation
title Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
title_full Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
title_fullStr Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
title_full_unstemmed Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
title_short Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
title_sort peroxisome proliferator activated receptor α reduces endothelin 1 caused cardiomyocyte hypertrophy by inhibiting nuclear factor κb and adiponectin
url http://dx.doi.org/10.1155/2016/5609121
work_keys_str_mv AT hsulungjen peroxisomeproliferatoractivatedreceptorareducesendothelin1causedcardiomyocytehypertrophybyinhibitingnuclearfactorkbandadiponectin
AT polenliu peroxisomeproliferatoractivatedreceptorareducesendothelin1causedcardiomyocytehypertrophybyinhibitingnuclearfactorkbandadiponectin
AT yunghsiangchen peroxisomeproliferatoractivatedreceptorareducesendothelin1causedcardiomyocytehypertrophybyinhibitingnuclearfactorkbandadiponectin
AT weihsianyin peroxisomeproliferatoractivatedreceptorareducesendothelin1causedcardiomyocytehypertrophybyinhibitingnuclearfactorkbandadiponectin
AT jawwenchen peroxisomeproliferatoractivatedreceptorareducesendothelin1causedcardiomyocytehypertrophybyinhibitingnuclearfactorkbandadiponectin
AT shingjonglin peroxisomeproliferatoractivatedreceptorareducesendothelin1causedcardiomyocytehypertrophybyinhibitingnuclearfactorkbandadiponectin